Status: Not yet recruiting
Real-World Pharmacokinetic/Pharmacodynamic Study of Eravacycline in Critically III Patients
The aim of this study is to evaluate the efficacy of Eravacycline in the treatment of patients with bacterial infection and to assess the pharmacokinetics of Eravacycline and to establish a population pharmacokinetic model of Eravacycline.
Participants needed: 100
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Sichuan Provincial People's HospitalUpdated: Nov 4, 2024
Eligibility criteria
Adult male or female aged 18-75 years [+4]
Urinary tract infection [+3]